Clinical Trial Update: Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 trial examining how metformin affects leptin transport in cerebrospinal fluid for obese individuals without type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity Without Type 2 Diabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Lille Catholic University | Conditions: Obesity Without Type 2 Diabetes, With BMI>30 | Phase 2 | Status: UNKNOWN